Side Effects of Weight Loss Injections: What Semaglutide Users Should Know

Nausea is the most frequently reported side effect and is usually most noticeable in the first days after a dose increase, not throughout the whole course.
Serious but uncommon events — including pancreatitis — require urgent medical attention; the MHRA issued a Drug Safety Update on GLP-1 medicines covering this in January 2026.
Patients can report unexpected or severe reactions via the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk.
Every semaglutide prescription from nume is preceded by a same-day clinical review; our prescribers walk through your individual risk profile before treatment begins.

The most common side effects of semaglutide weight loss injections are gastrointestinal: nausea, loose stools, constipation, and indigestion are all well-documented, typically peaking after a dose increase and settling within one to two weeks for most people. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; a GPhC-registered prescriber assesses your full health picture before it can be prescribed. Most people find the side effects manageable with a few practical adjustments, but knowing what to watch for, and when to get help, matters.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How Side Effects Typically Unfold Week by Week, and What Needs Urgent Attention

Step 1: What to expect in the first few weeks on semaglutide injections

For the majority of people starting Wegovy, the first pen brings the steepest learning curve. The 0.25 mg starting dose is designed as a tolerability measure, and many people sail through it with only mild queasiness after eating too quickly or too much. That said, nausea is real and can catch you off guard if you haven't been warned. Eating smaller portions, going slowly with fatty or spicy food, and staying well hydrated all help considerably, and our prescribers cover this during the consultation.

Other effects in the early weeks can include burping, indigestion, a general sense of fatigue, and occasional headaches. These are largely a consequence of slowed gastric emptying, semaglutide keeps food moving through your stomach more slowly, which is part of how it reduces hunger. Constipation and diarrhoea can both occur, sometimes alternating. For a fuller picture of the semaglutide injection side-effect profile, this overview on semaglutide injection side effects goes into more depth on each one.

Injection-site reactions (mild redness, a small lump, or a brief sting) are also common. Rotating between your abdomen, thigh, and upper arm reduces them. The Wegovy demonstration pen guide covers technique for those who want to get their first injection right first time. As a rule of thumb: if a side effect is unpleasant but fading over a few days, it fits the typical pattern. If it is worsening, it warrants a call to your prescriber.

Step 2: Side effects that tend to come and go with dose increases

The titration schedule for Wegovy moves upward roughly every four weeks. Each step up is another moment where the GI side effects can resurface, temporarily. This catches some patients off guard. The misconception worth putting to rest is that experiencing nausea at 1.0 mg, after feeling fine at 0.5 mg, means something has gone wrong. It almost always hasn't. The pattern simply repeats: discomfort, then adaptation, then stability.

Fatigue and dizziness can also surface at higher doses, particularly if food intake has dropped sharply and fluid intake hasn't kept pace. Getting enough protein across the day helps the body hold onto muscle while losing fat, which matters for energy levels. If nausea is severe enough to prevent eating or drinking at all, that is worth reporting to your prescriber promptly, because significant dehydration can put strain on the kidneys. The NHS medicines page on semaglutide lists the full spectrum of known side effects, including frequency data.

For those also reading about Ozempic (which is the same active ingredient) the side effect profile for weight loss injection users is similar, though Ozempic is licensed for type 2 diabetes, not weight management.

Step 3: When to get medical help, and what counts as urgent

Most semaglutide side effects are mild and time-limited. A handful are not, and it's worth knowing which is which before you start.

Get urgent medical attention for: severe stomach pain that spreads to the back, with or without vomiting. This pattern can indicate pancreatitis, a serious and uncommon condition associated with GLP-1 medicines. In January 2026 the MHRA issued a formal Drug Safety Update on this, reminding prescribers and patients to act quickly if these symptoms appear. Also seek prompt help for: signs of gallbladder problems (pain in the upper right abdomen, fever, yellowing of the skin or eyes); significant dehydration from prolonged vomiting or diarrhoea; any signs of a serious allergic reaction such as swelling of the face or throat, or difficulty breathing; and new or worsening thoughts of self-harm or low mood, which have been reported with this class of medicine.

These events are uncommon. They are not reasons to avoid treatment; they are reasons to be informed. If you experience a side effect you didn't expect, or one that concerns you, our aftercare team is available seven days a week. You can also report side effects directly to the MHRA through the Yellow Card scheme, patients, as well as clinicians, can make a report.

Step 4: Side effects specific to the semaglutide injection format (vs. the tablet)

Semaglutide is now available in two licensed forms for weight management: the weekly injection (Wegovy) and, since June 2026, an oral tablet. The injection carries a distinct but related side-effect consideration: the injection site itself. Reactions are usually minor but worth mentioning because some people find them more persistent at certain rotation sites. Keeping the needle perpendicular, letting the skin warm slightly before injecting, and cleaning the area first all help. Our Wegovy injections overview covers technique alongside clinical detail.

For anyone thinking about what semaglutide weight loss injections involve before committing to one format over another, the weight loss treatment overview lays out the options clearly. Our prescribers discuss which approach suits your circumstances as part of the free consultation, there is no pressure, and no obligation to start. Start your free consultation if you'd like that conversation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions